These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15926798)

  • 41. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
    Duncan JS; Haystead TA; Litchfield DW
    Methods Mol Biol; 2012; 795():119-34. PubMed ID: 21960219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duplexed, bead-based competitive assay for inhibitors of protein kinases.
    Simons PC; Young SM; Gibaja V; Lee WC; Josiah S; Edwards BS; Sklar LA
    Cytometry A; 2007 Jul; 71(7):451-9. PubMed ID: 17542028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening.
    Foloppe N; Fisher LM; Howes R; Potter A; Robertson AG; Surgenor AE
    Bioorg Med Chem; 2006 Jul; 14(14):4792-802. PubMed ID: 16574416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substrate screening of protein kinases: detection methods and combinatorial peptide libraries.
    Kim M; Shin DS; Kim J; Lee YS
    Biopolymers; 2010; 94(6):753-62. PubMed ID: 20564046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase.
    Townley R; Shapiro L
    Science; 2007 Mar; 315(5819):1726-9. PubMed ID: 17289942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of methyl-TROSY NMR to test allosteric models describing effects of nucleotide binding to aspartate transcarbamoylase.
    Velyvis A; Schachman HK; Kay LE
    J Mol Biol; 2009 Apr; 387(3):540-7. PubMed ID: 19302799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A priori inference of cross reactivity for drug-targeted kinases.
    Fernandez A; Maddipati S
    J Med Chem; 2006 Jun; 49(11):3092-100. PubMed ID: 16722629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors influencing the inhibition of protein kinases.
    Brockhoff M; Hau JC; Fontana P; Zimmermann C; Pover AD; Erdmann D; Chène P
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):194-200. PubMed ID: 21635207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase.
    Kedika SR; Udugamasooriya DG
    Org Biomol Chem; 2018 Sep; 16(35):6443-6449. PubMed ID: 30140808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of novel fragment compounds targeted against the pY pocket of v-Src SH2 by computational and NMR screening and thermodynamic evaluation.
    Taylor JD; Gilbert PJ; Williams MA; Pitt WR; Ladbury JE
    Proteins; 2007 Jun; 67(4):981-90. PubMed ID: 17393456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism.
    Luo L; Parrish CA; Nevins N; McNulty DE; Chaudhari AM; Carson JD; Sudakin V; Shaw AN; Lehr R; Zhao H; Sweitzer S; Lad L; Wood KW; Sakowicz R; Annan RS; Huang PS; Jackson JR; Dhanak D; Copeland RA; Auger KR
    Nat Chem Biol; 2007 Nov; 3(11):722-6. PubMed ID: 17922005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosine.
    Payne LS; Brown PM; Middleditch M; Baker E; Cooper GJ; Loomes KM
    Biochem J; 2008 Dec; 416(2):281-8. PubMed ID: 18637789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of ATP competitive protein kinase inhibition by Western blotting.
    Wang R; Thompson JE
    Anal Biochem; 2001 Dec; 299(1):110-2. PubMed ID: 11726192
    [No Abstract]   [Full Text] [Related]  

  • 56. Structural analysis of PI3-kinase isoforms: identification of residues enabling selective inhibition by small molecule ATP-competitive inhibitors.
    Zvelebil MJ; Waterfield MD; Shuttleworth SJ
    Arch Biochem Biophys; 2008 Sep; 477(2):404-10. PubMed ID: 18647592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure determination of protein-ligand complexes by transferred paramagnetic shifts.
    John M; Pintacuda G; Park AY; Dixon NE; Otting G
    J Am Chem Soc; 2006 Oct; 128(39):12910-6. PubMed ID: 17002387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Saturation transfer difference nuclear magnetic resonance study on the specific binding of ligand to protein.
    Ji Z; Yao Z; Liu M
    Anal Biochem; 2009 Feb; 385(2):380-2. PubMed ID: 19070584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distance measurements in disodium ATP hydrates by means of 31P double quantum two-dimensional solid-state NMR spectroscopy.
    Potrzebowski MJ; Gajda J; Ciesielski W; Montesinos IM
    J Magn Reson; 2006 Apr; 179(2):173-81. PubMed ID: 16360330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Refinement of the conformation of UDP-galactose bound to galactosyltransferase using the STD NMR intensity-restrained CORCEMA optimization.
    Jayalakshmi V; Biet T; Peters T; Krishna NR
    J Am Chem Soc; 2004 Jul; 126(28):8610-1. PubMed ID: 15250687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.